BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 16819376)

  • 1. Osteoporosis in pediatric patients suffering from chronic inflammatory bowel disease with and without steroid treatment.
    Walther F; Fusch C; Radke M; Beckert S; Findeisen A
    J Pediatr Gastroenterol Nutr; 2006 Jul; 43(1):42-51. PubMed ID: 16819376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone mineral density in Iranian patients with inflammatory bowel disease.
    Zali M; Bahari A; Firouzi F; Daryani NE; Aghazadeh R; Emam MM; Rezaie A; Shalmani HM; Naderi N; Maleki B; Sayyah A; Bashashati M; Jazayeri H; Zand S
    Int J Colorectal Dis; 2006 Dec; 21(8):758-66. PubMed ID: 16463035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone mineral density and nutritional status in children with chronic inflammatory bowel disease.
    Boot AM; Bouquet J; Krenning EP; de Muinck Keizer-Schrama SM
    Gut; 1998 Feb; 42(2):188-94. PubMed ID: 9536942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone mineral assessment by dual energy X-ray absorptiometry in children with inflammatory bowel disease: evaluation by age or bone area.
    Ahmed SF; Horrocks IA; Patterson T; Zaidi S; Ling SC; McGrogan P; Weaver LT
    J Pediatr Gastroenterol Nutr; 2004 Mar; 38(3):276-80. PubMed ID: 15076625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of risk factors for low bone mineral density in inflammatory bowel disease.
    Frei P; Fried M; Hungerbuhler V; Rammert C; Rousson V; Kullak-Ublick GA
    Digestion; 2006; 73(1):40-6. PubMed ID: 16543736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone mineral density in patients with inflammatory bowel disease: a population-based prospective two-year follow-up study.
    Jahnsen J; Falch JA; Mowinckel P; Aadland E
    Scand J Gastroenterol; 2004 Feb; 39(2):145-53. PubMed ID: 15000276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased bone density in inflammatory bowel disease is related to corticosteroid use and not disease diagnosis.
    Bernstein CN; Seeger LL; Sayre JW; Anton PA; Artinian L; Shanahan F
    J Bone Miner Res; 1995 Feb; 10(2):250-6. PubMed ID: 7754804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pathological bone density in chronic inflammatory bowel diseases--prevalence and risk factors].
    Von Tirpitz C; Pischulti G; Klaus J; Rieber A; Brückel J; Böhm BO; Adler G; Reinshagen M
    Z Gastroenterol; 1999 Jan; 37(1):5-12. PubMed ID: 10091278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Femoral neck osteopenia in patients with inflammatory bowel disease.
    Pollak RD; Karmeli F; Eliakim R; Ackerman Z; Tabb K; Rachmilewitz D
    Am J Gastroenterol; 1998 Sep; 93(9):1483-90. PubMed ID: 9732930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bone metabolism in 53 children and adolescents with chronic inflammatory bowel disease].
    Scheer K; Kratzsch J; Deutscher J; Gelbrich G; Borte G; Kiess W
    Klin Padiatr; 2004; 216(2):62-6. PubMed ID: 15106075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bone mineral density in inflammatory bowel diseases in children].
    Szumera M; Landowski P; Kamińska B; Góra-Gebka M; Popadiuk S; Renke J
    Med Wieku Rozwoj; 2006; 10(2):445-51. PubMed ID: 16825715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind placebo-controlled study of intravenous clodronate for prevention of steroid-induced bone loss in inflammatory bowel disease.
    Abitbol V; Briot K; Roux C; Roy C; Seksik P; Charachon A; Bouhnik Y; Coffin B; Allez M; Lamarque D; Chaussade S
    Clin Gastroenterol Hepatol; 2007 Oct; 5(10):1184-9. PubMed ID: 17683996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are adult patients with Laron syndrome osteopenic? A comparison between dual-energy X-ray absorptiometry and volumetric bone densities.
    Benbassat CA; Eshed V; Kamjin M; Laron Z
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4586-9. PubMed ID: 14557426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammation is the main determinant of low bone mineral density in pediatric inflammatory bowel disease.
    Paganelli M; Albanese C; Borrelli O; Civitelli F; Canitano N; Viola F; Passariello R; Cucchiara S
    Inflamm Bowel Dis; 2007 Apr; 13(4):416-23. PubMed ID: 17206686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen receptor alpha gene polymorphisms and bone mineral density in healthy children and young adults.
    Boot AM; van der Sluis IM; de Muinck Keizer-Schrama SM; van Meurs JB; Krenning EP; Pols HA; Uitterlinden AG
    Calcif Tissue Int; 2004 Jun; 74(6):495-500. PubMed ID: 15354856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteoporosis in lung transplantation candidates with end-stage pulmonary disease.
    Shane E; Silverberg SJ; Donovan D; Papadopoulos A; Staron RB; Addesso V; Jorgesen B; McGregor C; Schulman L
    Am J Med; 1996 Sep; 101(3):262-9. PubMed ID: 8873487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term effects of growth hormone (GH) treatment on body composition and bone mineral density in short children born small-for-gestational-age: six-year follow-up of a randomized controlled GH trial.
    Willemsen RH; Arends NJ; Bakker-van Waarde WM; Jansen M; van Mil EG; Mulder J; Odink RJ; Reeser M; Rongen-Westerlaken C; Stokvis-Brantsma WH; Waelkens JJ; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2007 Oct; 67(4):485-92. PubMed ID: 17561977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone density improves with disease remission in patients with inflammatory bowel disease.
    Reffitt DM; Meenan J; Sanderson JD; Jugdaohsingh R; Powell JJ; Thompson RP
    Eur J Gastroenterol Hepatol; 2003 Dec; 15(12):1267-73. PubMed ID: 14624148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimates of volumetric bone density from projectional measurements improve the discriminatory capability of dual X-ray absorptiometry.
    Jergas M; Breitenseher M; Glüer CC; Yu W; Genant HK
    J Bone Miner Res; 1995 Jul; 10(7):1101-10. PubMed ID: 7484286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous pamidronate in combination with calcium and vitamin D: highly effective in the treatment of low bone mineral density in inflammatory bowel disease.
    Stokkers PC; Deley M; Van Der Spek M; Verberne HJ; Van Deventer SJ; Hommes DW
    Scand J Gastroenterol; 2006 Feb; 41(2):200-4. PubMed ID: 16484125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.